Xupeng Mu

952 total citations
37 papers, 694 citations indexed

About

Xupeng Mu is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Xupeng Mu has authored 37 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Biomedical Engineering and 7 papers in Oncology. Recurrent topics in Xupeng Mu's work include Nanoplatforms for cancer theranostics (12 papers), RNA Interference and Gene Delivery (9 papers) and Nanoparticle-Based Drug Delivery (7 papers). Xupeng Mu is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), RNA Interference and Gene Delivery (9 papers) and Nanoparticle-Based Drug Delivery (7 papers). Xupeng Mu collaborates with scholars based in China, United States and Switzerland. Xupeng Mu's co-authors include Jinlan Jiang, Shaohua Yan, Meng Zhang, Jing Li, Fuqiang Zhang, Haibin Lu, Hongmei Zhang, Wenjing Zhang, Fei Yin and Yan Wang and has published in prestigious journals such as ACS Nano, Biochemical and Biophysical Research Communications and Nanoscale.

In The Last Decade

Xupeng Mu

37 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xupeng Mu China 15 378 309 225 93 63 37 694
Jinhyang Choi South Korea 12 229 0.6× 284 0.9× 180 0.8× 125 1.3× 100 1.6× 15 666
Yan Wei China 19 381 1.0× 296 1.0× 269 1.2× 143 1.5× 114 1.8× 28 866
Suo-Qin Tang China 12 295 0.8× 208 0.7× 241 1.1× 91 1.0× 58 0.9× 41 570
Marco Soster Italy 11 201 0.5× 195 0.6× 121 0.5× 73 0.8× 82 1.3× 15 597
Ella N. Hoogenboezem United States 6 265 0.7× 159 0.5× 186 0.8× 118 1.3× 67 1.1× 9 563
Wan Su Yun South Korea 16 241 0.6× 411 1.3× 225 1.0× 131 1.4× 88 1.4× 25 726
Isaac M. Adjei United States 15 253 0.7× 328 1.1× 188 0.8× 144 1.5× 161 2.6× 22 848
Qiaoya Lin China 11 369 1.0× 286 0.9× 215 1.0× 50 0.5× 122 1.9× 23 694
Rachel L. Mintz United States 14 292 0.8× 209 0.7× 117 0.5× 89 1.0× 94 1.5× 30 632

Countries citing papers authored by Xupeng Mu

Since Specialization
Citations

This map shows the geographic impact of Xupeng Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xupeng Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xupeng Mu more than expected).

Fields of papers citing papers by Xupeng Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xupeng Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xupeng Mu. The network helps show where Xupeng Mu may publish in the future.

Co-authorship network of co-authors of Xupeng Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Xupeng Mu. A scholar is included among the top collaborators of Xupeng Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xupeng Mu. Xupeng Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chengran, et al.. (2025). Cryo-trojan mesenchymal stem cells as non-living tumor-homing supercarriers for enhanced drug delivery and immune activation in prostate cancer. Materials Today Bio. 32. 101650–101650. 3 indexed citations
2.
Mu, Xupeng, et al.. (2025). Nanotechnology Advances Proteolysis Targeting Chimeras (PROTACs): Transition From Basic Research to Clinical Application. International Journal of Nanomedicine. Volume 20. 12177–12198. 1 indexed citations
3.
Wang, Chengran, Tianqi Dong, Yueyao Yang, et al.. (2025). Microbiome in prostate cancer: pathogenic mechanisms, multi-omics diagnostics, and synergistic therapies. Journal of Cancer Research and Clinical Oncology. 151(6). 178–178. 3 indexed citations
4.
Zhang, Dongqi, et al.. (2024). Polydopamine-Based Nanoparticles for Synergistic Chemotherapy of Prostate Cancer. International Journal of Nanomedicine. Volume 19. 6717–6730. 2 indexed citations
5.
Wang, Xiaoying, et al.. (2024). Research Progress of Disulfide Bond Based Tumor Microenvironment Targeted Drug Delivery System. International Journal of Nanomedicine. Volume 19. 7547–7566. 43 indexed citations
6.
Liu, Te, et al.. (2023). Depletion of gut microbiota resistance in 5×FAD mice enhances the therapeutic effect of mesenchymal stem cell-derived exosomes. Biomedicine & Pharmacotherapy. 161. 114455–114455. 12 indexed citations
7.
Mu, Xupeng, et al.. (2023). Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA. Frontiers in Oncology. 13. 1111855–1111855. 9 indexed citations
8.
Gao, Zihui, et al.. (2023). Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy. Biomedicine & Pharmacotherapy. 161. 114451–114451. 32 indexed citations
9.
Mu, Xupeng, et al.. (2023). TiO2 nanoparticles promote tumor metastasis by eliciting pro-metastatic extracellular vesicles. Journal of Nanobiotechnology. 21(1). 392–392. 2 indexed citations
10.
Yao, Hua, Xupeng Mu, Xiuying Li, et al.. (2022). Facile approach for surfactant-free synthesis of Au@ginsenoside Rh2 nanoparticles and researches on anticancer activity. Cancer Nanotechnology. 13(1). 3 indexed citations
11.
Zhang, Chi, et al.. (2022). Current progress of nanomedicine for prostate cancer diagnosis and treatment. Biomedicine & Pharmacotherapy. 155. 113714–113714. 25 indexed citations
12.
13.
Zhang, Meng, Fuqiang Zhang, Te Liu, et al.. (2020). <p>Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors</p>. International Journal of Nanomedicine. Volume 15. 10183–10197. 59 indexed citations
14.
Mu, Xupeng, et al.. (2019). Protein targeting chimeric molecules specific for dual bromodomain 4 (BRD4) and Polo-like kinase 1 (PLK1) proteins in acute myeloid leukemia cells. Biochemical and Biophysical Research Communications. 521(4). 833–839. 38 indexed citations
15.
Mu, Xupeng, et al.. (2018). Metadherin is an apoptotic modulator in prostate cancer through miR-342-3p regulation. Saudi Journal of Biological Sciences. 25(5). 975–981. 9 indexed citations
16.
Mu, Xupeng, Jing Li, Shaohua Yan, et al.. (2018). siRNA Delivery with Stem Cell Membrane-Coated Magnetic Nanoparticles for Imaging-Guided Photothermal Therapy and Gene Therapy. ACS Biomaterials Science & Engineering. 4(11). 3895–3905. 95 indexed citations
17.
Mu, Xupeng, et al.. (2015). The Histone Acetyltransferase MOF Promotes Induces Generation of Pluripotent Stem Cells. Cellular Reprogramming. 17(4). 259–267. 14 indexed citations
18.
Mu, Xupeng, et al.. (2015). Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA). Journal of Virological Methods. 228. 84–90. 7 indexed citations
19.
Mu, Xupeng, et al.. (2008). High-level expression, purification, and characterization of recombinant human basic fibroblast growth factor in Pichia pastoris. Protein Expression and Purification. 59(2). 282–288. 35 indexed citations
20.
Wang, Quancai, et al.. (2008). Expression, purification and characterization of recombinant human β-amyloid 1–42 in Pichia pastoris. Protein Expression and Purification. 63(2). 84–88. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinhyang Choi Breakdown of academic impact, for papers by Yan Wei Breakdown of academic impact, for papers by Suo-Qin Tang Breakdown of academic impact, for papers by Marco Soster Breakdown of academic impact, for papers by Ella N. Hoogenboezem Breakdown of academic impact, for papers by Wan Su Yun Breakdown of academic impact, for papers by Isaac M. Adjei Breakdown of academic impact, for papers by Qiaoya Lin Breakdown of academic impact, for papers by Rachel L. Mintz
Rankless by CCL
2026